The rs58542926 C>T (E167K) polymorphism in TM6SF2 was first found to be associated with NAFLD by GWAS in 2014 and encodes a missense protein resulting in loss-of-function[19]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.